Back

Identifying at-risk coronary lesions and options for their treatment: what clinical trials have taught us.

29 August 2017 (09:37 - 10:00)
Organised by:
Congress Presentation Part of: The Vulnerable Plaque Summit Cardiovascular risk ESC Premium Access ESC Congress 2017

About the speaker

Photo
Doctor Gregg Stone

Icahn School of Medicine at Mount Sinai, New York City (United States of America)

3 More presentations in this session

Presentation thumbnail
Pathology of ACS and the vulnerable plaque.
Professor J. Narula (Houston, US)
Slides Video
Presentation thumbnail
Imaging the vulnerable plaque - Current status.
Professor Z. Fayad (New York, US)
Slides Video
Presentation thumbnail
Biomarkers to identify at-risk individuals.
Professor W. Koenig (Munich, DE)
Slides Video

Access the full session

Session thumbnail
The Vulnerable Plaque Summit

The Event

Event poster

ESC Congress 2017

29 August 2017 09:37 CET
You may be interested in
thumbnail
Webinar
Percutaneous interventions in patients with coronary artery disease and specific clinical conditions - IC Core Curriculum 6
9 November 2022
thumbnail
Congress Presentation
Coronary plaque characteristics associated with major adverse cardiovascular events in atherosclerotic patients and lesions - A systematic review and meta-analysis
27 August 2022
thumbnail
Congress Presentation
Discordance between quantitative coronary angiography and fractional flow reserve or intravascular ultrasound: a substudy of the FLAVOUR trial
25 August 2023
thumbnail
Congress Presentation
Effects of combining coronary calcium score with treatment on plaque progression in familial coronary artery disease: CAUGHT-CAD RCT
1 September 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources